Tumor lysis syndrome: risk factors and treatment

Abstract

Tumor lysis syndrome is a typical oncological complication, characterized by hyperuricemia, hyperkalemia, hyperphosphatemia with secondary hypocalcemia, acidosis and acute renal failure. It occurs particularly in patients with lymphoproliferative diseases during therapy with potent myelosuppressive substances. Patients with solid tumors rarely develop a… (More)
DOI: 10.1007/s00508-005-0318-y

Topics

Cite this paper

@article{Hrl2005TumorLS, title={Tumor lysis syndrome: risk factors and treatment}, author={Walter Hermann H{\"o}rl}, journal={Wiener klinische Wochenschrift}, year={2005}, volume={117}, pages={7-17} }